Literature DB >> 6413551

A microbiological assay for the measurement of methotrexate in biological fluids.

G C Icke, R E Davis, J Thom.   

Abstract

A microbiological assay for the measurement of methotrexate has been designed, using a chloramphenicol resistant mutant of Lactobacillus casei as the test organism. The method is simple, precise and inexpensive. Results are not significantly different from those obtained using a methotrexate radioassay kit employing a competitive protein binding technique. However, where patients are being treated with co-trimoxazole, the competitive protein binding technique is unsuitable for measuring methotrexate levels due to the cross reactivity of the binder. This is not a problem with the microbiological assay described here, which is able to measure methotrexate in the presence of large doses of trimethoprim. The methods were not affected by the presence of seven commonly encountered antibiotics. These had negligible effect on either method up to concentrations of 100 mg/l.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413551      PMCID: PMC498486          DOI: 10.1136/jcp.36.10.1116

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  High-dose methotrexate in osteogenic sarcoma: a 5-year experience.

Authors:  N Jaffe; E Frei; H Watts; D Traggis
Journal:  Cancer Treat Rep       Date:  1978-02

Review 2.  High-dose methotrexate therapy--an area of uncertainty.

Authors:  J W Paxton
Journal:  Aust N Z J Med       Date:  1979-12

3.  Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.

Authors:  I Djerassi; C J Rominger; J S Kim; J Turchi; U Suvansri; D Hughes
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

4.  An automated method for the measurement of folate activity.

Authors:  R E Davis; D J Nicol; A Kelly
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

5.  Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.

Authors:  D D Von Hoff; J S Penta; L J Helman; M Slavik
Journal:  Cancer Treat Rep       Date:  1977-07

6.  Enzymatic assay for methotrexate in serum and cerebrospinal fluid.

Authors:  L C Falk; D R Clark; S M Kalman; T F Long
Journal:  Clin Chem       Date:  1976-06       Impact factor: 8.327

7.  Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis.

Authors:  W C Noble; P M White; H Baker
Journal:  J Invest Dermatol       Date:  1975-02       Impact factor: 8.551

8.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

9.  A rapid and specific radioimmunoassay for methotrexate.

Authors:  V Raso; R Schreiber
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.